The Scandinavian Propaten(®) trial - 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - a randomised clinical controlled multi-centre trial

Jes S. Lindholt, B Gottschalksen, N Johannesen, D Dueholm, H Ravn, E D Christensen, B Viddal, T Flørenes, G Pedersen, Martin Rasmussen, M Carstensen, N Grøndal, H Fasting

    108 Citations (Scopus)

    Abstract

    To compare 1-year potencies' of heparin-bonded PTFE [(Hb-PTFE) (Propaten(®))] grafts with those of ordinary polytetraflouroethylene (PTFE) grafts in a blinded, randomised, clinically controlled, multi-centre study.
    Original languageEnglish
    JournalEuropean Journal of Vascular and Endovascular Surgery
    Volume41
    Issue number5
    Pages (from-to)668-73
    Number of pages6
    ISSN1078-5884
    DOIs
    Publication statusPublished - 2011

    Keywords

    • Aged
    • Anastomosis, Surgical
    • Anticoagulants
    • Blood Vessel Prosthesis
    • Drug-Eluting Stents
    • Female
    • Femoral Artery
    • Follow-Up Studies
    • Heparin
    • Humans
    • Male
    • Peripheral Arterial Disease
    • Polytetrafluoroethylene
    • Popliteal Artery
    • Prosthesis Design
    • Retrospective Studies
    • Scandinavia
    • Treatment Outcome
    • Ultrasonography, Doppler, Duplex
    • Vascular Patency

    Fingerprint

    Dive into the research topics of 'The Scandinavian Propaten(®) trial - 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - a randomised clinical controlled multi-centre trial'. Together they form a unique fingerprint.

    Cite this